Can Novavax Win FDA Approval for COVID-19 Vaccine Before Year End? Analyst Weighs In

You can’t always get what you want, but if you try sometimes… You do get what you want?After initially being excluded from the U.S. government’s Operation Warp Speed (OWS) program, Novavax (NVAX) joined the list of companies eligible for federal support.On July 7, the vaccine specialist announced it will receive $1.6 billion from the federal government to support the development of its COVID-19 vaccine candidate, NVX-CoV2373. 5-star B.Riley FBR analyst Mayank Mamtani is impressed by the scale of the award itself, noting: “[T]his funding is the largest granted by OWS to date, correlating with the (1) robustness of preclinical data …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.